Acromegaly Clinical Trials

A listing of Acromegaly medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UPDATED

Birmingham Alabama 35294

Patients are needed to participate in a clinical research study of Octreotide capsules, Injectable Somatostatin Analogs (octreotide or lanreotide) and Cabergoline to evaluate Acromegaly

Arizona

Advanced Research
Peoria Arizona 85381

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

California

UCLA School of Medicine
Los Angeles California 90095

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Coastal Metabolic Research Center University Medical Center, Dept. of Endocrinology
Ventura California 93003

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

View More ▼

UPDATED

La Jolla California 92037

A Phase 4 clinical study for patients using Pasireotide

UPDATED

Los Angeles California 90048

A Phase 4 clinical study for patients using Pasireotide

UPDATED

Los Angeles California 90033

Patients are needed to participate in a clinical research study of Octreotide capsules, Injectable Somatostatin Analogs (octreotide or lanreotide) and Cabergoline to evaluate Acromegaly

UPDATED

Los Angeles California 90048

Patients are needed to participate in a clinical research study of Octreotide capsules, Injectable Somatostatin Analogs (octreotide or lanreotide) and Cabergoline to evaluate Acromegaly

UPDATED

Stanford California 94304

A Phase 4 clinical study for patients using Pasireotide

UPDATED

Stanford California 94305

Patients are needed to participate in a clinical research study of Octreotide capsules, Injectable Somatostatin Analogs (octreotide or lanreotide) and Cabergoline to evaluate Acromegaly

Additional Locations California

A clinical research study for the treatment of Cushing's Disease, or Acromegaly

Los Angeles California 90048

Patients are needed to participate in a clinical research study evaluating Sandostatin LAR for the treatment of Acromegaly

Torrance California 90502

A clinical research study for the treatment of Cushing's Disease, or Acromegaly

Ventura California 93003

A clinical research study for the treatment of Cushing's Disease, or Acromegaly

Colorado

UPDATED

Aurora Colorado 80045

Patients are needed to participate in a clinical research study of Octreotide capsules, Injectable Somatostatin Analogs (octreotide or lanreotide) and Cabergoline to evaluate Acromegaly

Florida

Jacksonville Florida 32223

A clinical research study for the treatment of Cushing's Disease, or Acromegaly

Georgia

UPDATED

Atlanta Georgia 30322

Patients are needed to participate in a clinical research study of Octreotide capsules, Injectable Somatostatin Analogs (octreotide or lanreotide) and Cabergoline to evaluate Acromegaly

Illinois

UPDATED

Chicago Illinois 60611

Patients are needed to participate in a clinical research study of Octreotide capsules, Injectable Somatostatin Analogs (octreotide or lanreotide) and Cabergoline to evaluate Acromegaly

UPDATED

Chicago Illinois 60612

Patients are needed to participate in a clinical research study of Octreotide capsules, Injectable Somatostatin Analogs (octreotide or lanreotide) and Cabergoline to evaluate Acromegaly

Maryland

Johns Hopkins University School of Medicine Division of Endocrinology, Diabetes & Metabolism
Baltimore Maryland 21287

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

View More ▼

UPDATED

Baltimore Maryland 21287

Patients are needed to participate in a clinical research study of Octreotide capsules, Injectable Somatostatin Analogs (octreotide or lanreotide) and Cabergoline to evaluate Acromegaly

Massachusetts

Massachusetts General Hospital
Boston Massachusetts 02114

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

View More ▼

UPDATED

Boston Massachusetts 02114

Patients are needed to participate in a clinical research study of Octreotide capsules, Injectable Somatostatin Analogs (octreotide or lanreotide) and Cabergoline to evaluate Acromegaly

Boston Massachusetts 02114

A clinical trial seeking patients for a research study for the treatment of Acromegaly

Michigan

University of Michigan Medical Center Rares de la Surrénale, Service d'Endocrinologie, Hôpital Cochin
Ann Arbor Michigan 48109

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

View More ▼

UPDATED

Ann Arbor Michigan 48109-0944

A Phase 4 clinical study for patients using Pasireotide

Missouri

UPDATED

St. Louis Missouri 63110

Patients are needed to participate in a clinical research study of Octreotide capsules, Injectable Somatostatin Analogs (octreotide or lanreotide) and Cabergoline to evaluate Acromegaly

St. Louis Missouri 63110

A clinical research study for the treatment of Cushing's Disease, or Acromegaly

Montana

Great Falls Montana 59405

A clinical research study for the treatment of Cushing's Disease, or Acromegaly

New Jersey

UPDATED

New Brunswick New Jersey 08903

Patients are needed to participate in a clinical research study of Octreotide capsules, Injectable Somatostatin Analogs (octreotide or lanreotide) and Cabergoline to evaluate Acromegaly

New Brunswick New Jersey 08901

A clinical research study for the treatment of Cushing's Disease, or Acromegaly

New Mexico

University of New Mexico HSC
Albuquerque New Mexico 87131

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

View More ▼

Albuquerque New Mexico 87131

A clinical research study for the treatment of Cushing's Disease, or Acromegaly

New York

Icahn School of Medicine at Mount Sinai
New York New York 10029

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

View More ▼

UPDATED

New York New York 10029

A Phase 4 clinical study for patients using Pasireotide

UPDATED

New York New York 10065

A Phase 4 clinical study for patients using Pasireotide

UPDATED

New York New York 10032

Patients are needed to participate in a clinical research study of Octreotide capsules, Injectable Somatostatin Analogs (octreotide or lanreotide) and Cabergoline to evaluate Acromegaly

New York New York 10029

A clinical research study for the treatment of Cushing's Disease, or Acromegaly

New York New York 10075

A clinical research study for the treatment of Cushing's Disease, or Acromegaly

New York New York 10032

A clinical research study for the treatment of Cushing's Disease, or Acromegaly

Ohio

Cleveland Clinic Endocrinology
Cleveland Ohio 44195

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

CarePoint East
Columbus Ohio 43203

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

View More ▼

UPDATED

Columbus Ohio 43203

Patients are needed to participate in a clinical research study of Octreotide capsules, Injectable Somatostatin Analogs (octreotide or lanreotide) and Cabergoline to evaluate Acromegaly

Oregon

Oregon Health & Science University
Portland Oregon

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Pennsylvania

University of Pennslyvania Smilow Center for Translational Research
Philadelphia Pennsylvania 19104-5160

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

View More ▼

UPDATED

Philadelphia Pennsylvania 19107

Patients are needed to participate in a clinical research study of Octreotide capsules, Injectable Somatostatin Analogs (octreotide or lanreotide) and Cabergoline to evaluate Acromegaly

UPDATED

Pittsburgh Pennsylvania 15212

Patients are needed to participate in a clinical research study of Octreotide capsules, Injectable Somatostatin Analogs (octreotide or lanreotide) and Cabergoline to evaluate Acromegaly

Pittsburgh Pennsylvania 15212

A clinical research study for the treatment of Cushing's Disease, or Acromegaly

Rhode Island

Rhode Island Hospital, Hallett Center for Diabetes and Endocrinology
East Providence Rhode Island 02914

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Tennessee

UPDATED

Nashville Tennessee 37203

Patients are needed to participate in a clinical research study of Octreotide capsules, Injectable Somatostatin Analogs (octreotide or lanreotide) and Cabergoline to evaluate Acromegaly